Growing evidence has revealed that epidermal growth factor receptor (EGFR) is highly expressed in NSCLC cells, and its activation via ligand binding (epithermal growth factor) can induce phosphorylation via tyrosine kinase activity and consequently promote tumor cell proliferation [1]. This evidence concerns the gene EGFR and neoplasm.